Oramed Pharmaceuticals Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated February 28, 2011, details the results of the 2011 Annual Meeting of Shareholders held on February 24, 2011. Oramed Pharmaceuticals Inc., incorporated in Nevada, reported the voting outcomes for four key proposals submitted to its security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results rather than financial performance.
Material Changes and Voting Results
All four proposals submitted to the shareholders were approved by the requisite thresholds. The specific results were as follows:
- Re-election of Directors: Five directors were re-elected. Voting totals ranged from approximately 26.6 million "FOR" votes to roughly 101,000 "WITHHELD" votes per director. There were 8,803,899 broker non-votes.
- Ratification of Auditors: Shareholders ratified the appointment of Kesselman & Kesselman (a member of PricewaterhouseCoopers International Limited) as the auditors for the 2011 fiscal year. The vote was 35,444,735 "FOR", 69,989 "AGAINST", and 15,034 "ABSTAIN".
- Reverse Stock Split Authorization: Shareholders authorized the Board to effect a reverse stock split at a ratio not to exceed one-for-eighteen. The vote was 33,632,662 "FOR", 1,876,979 "AGAINST", and 20,117 "ABSTAIN".
- Reincorporation: Shareholders approved the reincorporation of the Company from the State of Nevada to the State of Delaware. The vote was 26,654,427 "FOR", 56,157 "AGAINST", and 0 "ABSTAIN". There were 8,803,899 broker non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, or contingencies beyond the procedural approval of the reverse stock split and reincorporation.
Key Facts for Investor Verification
- Verify the implementation timeline for the authorized reverse stock split (up to 1-for-18).
- Confirm the completion of the reincorporation process from Nevada to Delaware.
- Review the Definitive Proxy Statement filed on January 31, 2011, for detailed descriptions of the proposals.
- Note the significant number of broker non-votes (8,803,899) regarding the director elections and reincorporation.